1. Home
  2. HSHP vs HRTX Comparison

HSHP vs HRTX Comparison

Compare HSHP & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSHP
  • HRTX
  • Stock Information
  • Founded
  • HSHP 2021
  • HRTX 1983
  • Country
  • HSHP Bermuda
  • HRTX United States
  • Employees
  • HSHP N/A
  • HRTX N/A
  • Industry
  • HSHP
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSHP
  • HRTX Health Care
  • Exchange
  • HSHP Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • HSHP 248.0M
  • HRTX 270.7M
  • IPO Year
  • HSHP 2023
  • HRTX 1987
  • Fundamental
  • Price
  • HSHP $4.59
  • HRTX $1.84
  • Analyst Decision
  • HSHP
  • HRTX Strong Buy
  • Analyst Count
  • HSHP 0
  • HRTX 3
  • Target Price
  • HSHP N/A
  • HRTX $5.67
  • AVG Volume (30 Days)
  • HSHP 223.2K
  • HRTX 1.1M
  • Earning Date
  • HSHP 05-20-2025
  • HRTX 05-06-2025
  • Dividend Yield
  • HSHP 10.15%
  • HRTX N/A
  • EPS Growth
  • HSHP 1123.58
  • HRTX N/A
  • EPS
  • HSHP 0.48
  • HRTX N/A
  • Revenue
  • HSHP $123,580,000.00
  • HRTX $144,285,000.00
  • Revenue This Year
  • HSHP $11.04
  • HRTX $11.81
  • Revenue Next Year
  • HSHP $26.01
  • HRTX $15.79
  • P/E Ratio
  • HSHP $10.12
  • HRTX N/A
  • Revenue Growth
  • HSHP 236.40
  • HRTX 13.57
  • 52 Week Low
  • HSHP $4.29
  • HRTX $1.04
  • 52 Week High
  • HSHP $9.76
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • HSHP 37.02
  • HRTX 39.27
  • Support Level
  • HSHP $4.48
  • HRTX $1.65
  • Resistance Level
  • HSHP $4.84
  • HRTX $2.00
  • Average True Range (ATR)
  • HSHP 0.25
  • HRTX 0.14
  • MACD
  • HSHP -0.07
  • HRTX -0.03
  • Stochastic Oscillator
  • HSHP 20.83
  • HRTX 30.16

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: